Eva Hellström‐Lindberg

1988–2025 年に発表

別表記
Eva Hellström-Lindberg · Eva Hellström Lindberg · Eva Hellstrom-Lindberg
130
論文数
33,091
被引用数
83
h 指数
122
i10 指数

被引用数

Eva Hellström‐Lindberg の年別被引用数1966 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 2 件1991 年: 被引用 7 件1992 年: 被引用 6 件1993 年: 被引用 6 件1994 年: 被引用 6 件1995 年: 被引用 7 件1996 年: 被引用 20 件1997 年: 被引用 16 件1998 年: 被引用 34 件1999 年: 被引用 27 件2000 年: 被引用 36 件2001 年: 被引用 38 件2002 年: 被引用 47 件2003 年: 被引用 62 件2004 年: 被引用 53 件2005 年: 被引用 58 件2006 年: 被引用 98 件2007 年: 被引用 79 件2008 年: 被引用 94 件2009 年: 被引用 117 件2010 年: 被引用 153 件2011 年: 被引用 222 件2012 年: 被引用 257 件2013 年: 被引用 287 件2014 年: 被引用 329 件2015 年: 被引用 296 件2016 年: 被引用 333 件2017 年: 被引用 266 件2018 年: 被引用 277 件2019 年: 被引用 784 件2020 年: 被引用 869 件2021 年: 被引用 900 件2022 年: 被引用 719 件2023 年: 被引用 791 件2024 年: 被引用 1,196 件2025 年: 被引用 541 件2026 年: 被引用 8 件1967〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,758 件、この内訳の 25.8%ドイツ: 引用元論文 876 件、この内訳の 8.2%イギリス: 引用元論文 787 件、この内訳の 7.3%イタリア: 引用元論文 745 件、この内訳の 7%中国: 引用元論文 617 件、この内訳の 5.8%フランス: 引用元論文 616 件、この内訳の 5.7%スペイン: 引用元論文 410 件、この内訳の 3.8%カナダ: 引用元論文 348 件、この内訳の 3.2%スウェーデン: 引用元論文 338 件、この内訳の 3.2%オランダ: 引用元論文 289 件、この内訳の 2.7%日本: 引用元論文 265 件、この内訳の 2.5%オーストラリア: 引用元論文 264 件、この内訳の 2.5%
0%25.8%その他 22.3%

分野

  • Medicine59.7%
  • Biochemistry, Genetics and Molecular Biology33%
  • Immunology and Microbiology5.2%
  • Computer Science0.6%
  • Neuroscience0.4%
  • Agricultural and Biological Sciences0.3%
  • その他0.8%

トピック

  • Acute Myeloid Leukemia Research15.7%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment6.3%
  • RNA modifications and cancer3.9%
  • Epigenetics and DNA Methylation3%
  • RNA Research and Splicing2.8%
  • Inflammatory Bowel Disease2.8%
  • その他65.5%

共著者

全論文

検索で開く
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 被引用: 2,693

  2. Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Akifumi Takaori‐Kondo, Takayuki Ishikawa, Shigeru Chiba, Senji Kasahara, Yasushi Miyazaki, Agnès Viale, Kety Huberman, Pierre Fenaux, Monika Beličková, Michael R. Savona, Virginia M. Klimek, Fábio Pires de Souza Santos, Jacqueline Boultwood, Ιoannis Kotsianidis, Valeria Santini, Françesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Kazuma Ohyashiki, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Luca Malcovati, Mario Cazzola, Seishi Ogawa, Eva Hellström‐Lindberg, Elli Papaemmanuil - NEJM Evidence 2022 被引用: 813

  3. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Boultwood, Fábio Pires de Souza Santos, Julie Schanz, Senji Kasahara, Takayuki Ishikawa, Hisashi Tsurumi, Akifumi Takaori‐Kondo, Toru Kiguchi, Chantana Polprasert, John M. Bennett, Virginia M. Klimek, Michael R. Savona, Monika Beličková, Christina Ganster, Laura Palomo, Guillermo Sanz, Lionel Adès, Matteo Giovanni Della Porta, Harold K. Elias, Alexandra Smith, Yesenia Werner, Minal Patel, Agnès Viale, Katelynd Vanness, Donna Neuberg, Kristen E. Stevenson, Kamal Menghrajani, Kelly L. Bolton, Pierre Fenaux, Andrea Pellagatti, Uwe Platzbecker, Michael Heuser, Peter Valent, Shigeru Chiba, Yasushi Miyazaki, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Yoshiko Atsuta, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Peter L. Greenberg, Mario Cazzola, Eva Hellström-Lindberg, Seishi Ogawa, Elli Papaemmanuil - Nature Medicine 2020 被引用: 636

  4. Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells

    著者: , , , , , , , , , , , , , , , , , , , , - Cell 2018 被引用: 573

  5. Clinical and biological implications of driver mutations in myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony R. Green, Jacqueline Boultwood, Paresh Vyas, Eva Hellström‐Lindberg, David Bowen, Mario Cazzola, Michael R. Stratton, Peter J. Campbell - Blood 2013 被引用: 1,832

  6. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2009 被引用: 2,640

  7. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

    著者: , , , , , , , , , , - Blood 2009 被引用: 4,416

  8. Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amer M. Zeidan, Lionel Adès, Amit Verma, Michael R. Savona, Abderrahmane Laadem, Aziz Benzohra, Jennie Zhang, Anita Rampersad, Diana Dunshee, Peter G. Linde, Matthew L. Sherman, Rami S. Komrokji, Alan F. List - New England Journal of Medicine 2020 被引用: 537

  9. SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E. Joanna Baxter, J Score, Anna Gallì, Matteo Giovanni Della Porta, Erica Travaglino, Michael J. Groves, Sudhir Tauro, Nikhil C. Munshi, Kristina Anderson, Adel K. El‐Naggar, Andrej Fischer, Ville Mustonen, Alan J. Warren, Nicholas C.P. Cross, Anthony R. Green, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell - New England Journal of Medicine 2011 被引用: 1,216

  10. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 被引用: 208

  11. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Detlef Haase, Heinz Tüchler, Peter L. Greenberg, Seishi Ogawa, Eva Hellström‐Lindberg, Mario Cazzola - Blood 2020 被引用: 293

  12. Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome

    著者: , , , , , , , , , , , , , , , , , - Nature Cell Biology 2022 被引用: 130

  13. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michaëla Fontenay, Olivier Kosmider, Michal Bar‐Natan, David P. Steensma, Richard M. Stone, Michael Heuser, Felicitas Thol, Mario Cazzola, Luca Malcovati, Aly Karsan, Christina Ganster, Eva Hellström‐Lindberg, Jacqueline Boultwood, Andrea Pellagatti, Valeria Santini, Lynn Quek, Paresh Vyas, Heinz Tüchler, Peter L. Greenberg, Rafael Bejar - Leukemia 2019 被引用: 259

  14. Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip Scheinberg, Reinhard Stauder, Arjan A. van de Loosdrecht, Andrew H. Wei, Mikkael A. Sekeres, Pierre Fenaux - Blood 2023 被引用: 92

  15. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2013 被引用: 667

  16. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2015 被引用: 428

  17. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia

    著者: , , , , , , , , , , , , , , , , , - Nature Communications 2018 被引用: 184

  18. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matteo Della Porta, Kety Huberman, Pierre Fenaux, Monika Beličková, Michael R. Savona, Virginia M. Klimek, Fábio Pires de Souza Santos, Jacqueline Boultwood, Ιoannis Kotsianidis, Valeria Santini, Françesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Seishi Ogawa, Michaëla Fontenay, Joop H. Jansen, José Cervera, Benjamin L. Ebert, Rafael Bejar, Peter L. Greenberg, Norbert Gattermann, Luca Malcovati, Mario Cazzola, David B. Beck, Eva Hellström‐Lindberg, Elli Papaemmanuil - Blood 2024 被引用: 49

  19. Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

    著者: , , , , , , , , , , , , , , , - Blood 2018 被引用: 178

  20. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2018 被引用: 250

  21. Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 194

  22. Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 958

  23. TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 460

  24. Molecular taxonomy of myelodysplastic syndromes and its clinical implications

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matteo Giovanni Della Porta, Pierre Fenaux, Monika Beličková, Michael R. Savona, Virginia M. Klimek, Fábio Pires de Souza Santos, Jacqueline Boultwood, Ιoannis Kotsianidis, Valeria Santini, Françesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Luca Malcovati, Seishi Ogawa, M. Cazzola, Eva Hellström‐Lindberg, Elli Papaemmanuil - Blood 2024 被引用: 73